Roger G. Stoll Phd - May 23, 2024 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Role
Director
Signature
/s/ David Hoffman, Attorney-in-Fact
Stock symbol
DCTH
Transactions as of
May 23, 2024
Transactions value $
$0
Form type
4
Date filed
5/28/2024, 04:23 PM
Previous filing
Jun 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DCTH Stock Option (Right to Buy) Disposed to Issuer $0 -142 -100% $0.00* 0 May 23, 2024 Common Stock 142 $196.70 Direct F1, F2
transaction DCTH Stock Option (Right to Buy) Award $0 +142 $0.00 142 May 23, 2024 Common Stock 142 $196.70 Direct F2
transaction DCTH Stock Option (Right to Buy) Disposed to Issuer $0 -40K -100% $0.00* 0 May 23, 2024 Common Stock 40K $11.67 Direct F3
transaction DCTH Stock Option (Right to Buy) Award $0 +40K $0.00 40K May 23, 2024 Common Stock 40K $11.67 Direct F3
transaction DCTH Stock Option (Right to Buy) Disposed to Issuer $0 -9K -100% $0.00* 0 May 23, 2024 Common Stock 9K $10.16 Direct F4
transaction DCTH Stock Option (Right to Buy) Award $0 +9K $0.00 9K May 23, 2024 Common Stock 9K $10.16 Direct F4
transaction DCTH Stock Option (Right to Buy) Disposed to Issuer $0 -9K -100% $0.00* 0 May 23, 2024 Common Stock 9K $6.24 Direct F5
transaction DCTH Stock Option (Right to Buy) Award $0 +9K $0.00 9K May 23, 2024 Common Stock 9K $6.24 Direct F5
transaction DCTH Stock Option (Right to Buy) Disposed to Issuer $0 -19.7K -100% $0.00* 0 May 23, 2024 Common Stock 19.7K $7.25 Direct F6
transaction DCTH Stock Option (Right to Buy) Award $0 +19.7K $0.00 19.7K May 23, 2024 Common Stock 19.7K $7.25 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was previously reported as covering 100,000 shares at an exercise price of $0.281 per share, but was adjusted to reflect the stock split that occurred on December 24, 2019.
F2 The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on February 1, 2019 and is fully vested.
F3 The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 23, 2020 and is fully vested.
F4 The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on August 5, 2021 and is fully vested.
F5 The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 4, 2022 and is fully vested.
F6 The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 12, 2023 and is fully vested.